Healthcare professionals will soon be able to offer women the first vaginal estrogen product that treats both the vasomotor and vaginal symptoms of menopause. The FDA recently approved estradiol (Femring, Galen Holdings) vaginal ring for the treatment of moderate to severe vasomotor symptoms associated with menopause and treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause. Femring will be available in pharmacies in June.
Ohio's Catalyst program is awarding pharmacists who cut unnecessary Medicaid drug costs in nursing homes
ASCP's Tim Webster to retire
In the wake of an FDA letter warning of civil and criminal liabilities for drug reimportation, American pharmacists are being urged to resist offers to partner with Canadian pharmacies serving U.S. seniors.
Products recommendations and gender differences
Minimum necessary rule
Healthcare providers can now treat HIV-infected patients with an antiretroviral drug that is unlike any other. The FDA recently granted accelerated approval of enfuvirtide (Fuzeon, Roche/Trimeris) to be used in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV-1 infection despite ongoing antiretroviral therapy. Enfuvirtide is approved for use in adults and children ages 6 years and older. It is currently available in pharmacies.
New clinical developments are improving the quality of life and increasing the survival time of lung cancer patients.
Frost & Sullivan provides pharmaceutical industry outlook 2003
Highlights of NACDS distribution conference
Drug errors involving Temodar
Oxytrol - New patch for treatment of overactive bladder.
Rx discount cards are costly to pharmacies, according to Dave Schuetz, R.Ph.
Top 200 brand and generic drugs of 2002 by dollars
Investments in generic firms.
IMS generic industry forecast.
Glaxo apotex patent case
Generic approvals for the first time in 2002.
GPhA says 2003 was a good year for the generic drug industry.
TrialCard partners with Duke, UNC and the NC Mental Health System for Pilot program
Top 200 brand and generic drugs sold in 2002 by units
Pharmacists must know the rules to succeed in the Medicare Part B market
The FDA recently approved tazarotene (Avage, Allergan) 0.1% cream as an adjunctive agent for use in the palliation of fine facial wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs. Avage became available in pharmacies in January.
New guidelines urge caution over hang time for lipid infusions to prevent catheter-related infections
New installment of HIPAA column on notice of privacy practices
Most pharmacists are working hard, earning good money, and loving it.
Pharmacy associations are filing lawsuits to stop states' Medicaid program from reducing pharmacy reimbursement and/or implementing co-pays.
Stattera (Atomoxetine) by Lilly for use in patients with attention deficit/hyperactivity disorder.
One half of the Iowa communnity pharmacists in 117 participating pharmacies in a Medicaid program failed to provide the pharmaceutical care services they were trained to offer and two thirds of eligible patients never received the services, according to a study.
